Reportedly, ING5 expression was decreased in many malignancies, including breast cancer [11], bladder cancer [12], gastric cancer [13], lung cancer [14], head and neck squamous cell carcinoma [15]. This evidence concerns the gene ING5 and breast carcinoma.